CryoLife Inc. (NYSE:CRY) made a big play yesterday for the mechanical heart valve space with a $130 million deal to buy On-X Life Technologies. On-X makes an aortic valve replacement and is developing a mitral chord repair device called Chord-X. The Austin, Texas-based company put up sales of about $33 million last year, CryoLife said. The deal calls […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Biotronik wins 2 FDA clearances: Iperia MRI-safe ICD and Astron peripheral stent
Biotronik said today it won FDA premarket approval for its latest family of MRI compatible implantable cardioverter defibrillators and won another premarket approval for its Astron peripheral self-expanding stent system. The company’s ProMRI ICD portfolio approval includes the DF-1 and DF4 configured Iperia DR-T, the Iperia Dx hybrid ICD and the Inventra ProMRI Dx which […]
Canada clears Medtronic Evera MRI SureScan ICD
Medtronic (NYSE:MDT) said today it won license approval from Health Canada for its Evera MRI-compatible SureScan implantable cardioverter defibrillator system. The Evera MRI SureScan ICD is licensed for MRI scans when needed on any part of the body, according to Fridley, Minn-based Medtronic. The licensing includes both the Evera MRI ICD and Sprint Quattro Secure MRI […]
FDA clears Zoll LifeVest wearable cardioverter defib for children
Zoll Medical won FDA premarket approval for its LifeVest wearable cardioverter defibrillator designed for children who are at risk for sudden cardiac arrest but aren’t candidates for an implantable defibrillator, according to an FDA release. The LifeVest is the only wearable cardioverter defibrillator that monitors the heart continuously for abnormal heart arrhythmias and responds automatically, […]
Xeltis snags $3.2m extension for Series B, closes round with $32m
Xeltis said today it brought in an extra $3.2 million (EU €3 million) extension for its Series B financing round, bringing the total up to $32.4 million (€30 million) for its bioabsorbable cardiovascular valve platform. Xeltis’ is designing a platform of bioabsorbable cardiovascular valves and vessels, starting with the pulmonary valve, designed to allow endogenous […]
AtriCure launches study of combined surgical, catheter afib ablations
AtriCure (NSDQ:ATRC) said today that it launched a clinical trial comparing a combined ablation approach with catheter ablation in patients with persistent atrial fibrillation. The 1st subject in the more-than-200-patient CEASE AF study was treated by co-principal investigator Dr. Nicolas Doll of the Sana Heart Center in Stuttgart, Germany, West Chester, Ohio-based AtriCure said. The trial is designed to compare […]
LuxCath heart device sees 1st use in treating arrhythmia, AFIB
LuxCath said today its catheter-based ablation device was used in its 1st procedure to treat arrhythmia patients, including patients with atrial fibrillation. The surgeries were led by Mount Sinai Hospital arrhythmia services director Dr. Vivek Reddy. LuxCath’s catheter-based ablation device can assess tissue contact, visualize lesions and detect lesion gaps in real time, the company […]
Svelte Medical granted CE Mark for Slender IDS drug-eluting stent catheter
Svelte Medical Systems said today it won CE Mark approval in the European Union for its Slender sirolimus-eluting coronary stent-on-a-wire integrated delivery system designed to treat coronary artery disease. The Slender IDS is the lowest-profile drug-eluting stent on the market, according to the New Providence, N.J.-based company. Approval in the EU came based on data […]
Study: Boston Scientific’s Watchman cheaper than drugs in reducing afib stroke risk
A study comparing the stroke risk for atrial fibrillation patients treated with Boston Scientific‘s (NYSE:BSX) Watchman device with the anticoagulant drug warfarin and non-warfarin oral anticoagulants found Watchman to be more cost-effective than its counterparts. Watchman is a catheter-delivered cardiac implant designed to close off the left atrial appendage, to prevent blood clots from forming there that could […]
FDA calls advisory panel for leadless pacemakers
The FDA plans to ask an expert panel to come up with some guidelines for 1 of the next frontiers in cardiac rhythm management, the leadless pacemaker. Medtronic (NYSE:MDT) and St. Jude Medical (NYSE:STJ) have each developed tiny pacers designed for transcatheter placement within the heart, eliminating the need for the wire leads used with conventional pacemakers; Boston Scientific (NYSE:BSX), which […]
BTG wins FDA 510(k) for radiopaque beads, touts PneumRx coil study
BTG said today it won FDA 510(k) clearance for its LC Bead Lumi radiopaque embolic beads designed for embolization of hypervascular tumors and arteriovenous malformations and touted results from the Renew study of its PneumRx endobronchial coil implant. The Lumi was designed with radiopacity tech that allows for real-time tracking of bead location during embolization procedures, London-based BTG […]